Cetera Investment Advisers
GILD icon

Cetera Investment Advisers’s Gilead Sciences GILD Stock Holding History

Cetera Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.4M Sell
404,797
-2,789
-0.7% -$391K 0.06% 334
2025
Q4 		$50M Buy
407,586
+17,406
+4% +$2.12M 0.05% 349
2025
Q3 		$43.3M Buy
390,180
+124,881
+47% +$14.2M 0.05% 371
2025
Q2 		$29.4M Buy
265,299
+21,966
+9% +$2.34M 0.05% 384
2025
Q1 		$27.3M Buy
243,333
+13,389
+6% +$1.38M 0.05% 364
2024
Q4 		$21.2M Sell
229,944
-3,422
-1% -$308K 0.04% 407
2024
Q3 		$19.6M Buy
233,366
+15,664
+7% +$1.2M 0.04% 423
2024
Q2 		$14.9M Buy
217,702
+3,801
+2% +$254K 0.03% 496
2024
Q1 		$15.7M Buy
213,901
+119,909
+128% +$9.22M 0.04% 476
2023
Q4 		$7.61M Buy
93,992
+6,424
+7% +$500K 0.06% 303
2023
Q3 		$6.56M Sell
87,568
-3,165
-3% -$243K 0.06% 331
2023
Q2 		$6.99M Sell
90,733
-6,797
-7% -$542K 0.06% 305
2023
Q1 		$8.09M Sell
97,530
-3,464
-3% -$287K 0.07% 256
2022
Q4 		$8.67M Buy
100,994
+38,276
+61% +$3.03M 0.08% 239
2022
Q3 		$3.87M Sell
62,718
-4,364
-7% -$275K 0.08% 272
2022
Q2 		$4.15M Buy
67,082
+9,115
+16% +$564K 0.07% 304
2022
Q1 		$3.45M Buy
57,967
+4,877
+9% +$312K 0.05% 381
2021
Q4 		$3.85M Sell
53,090
-19,828
-27% -$1.37M 0.06% 356
2021
Q3 		$5.09M Sell
72,918
-1,710
-2% -$120K 0.08% 269
2021
Q2 		$5.14M Buy
74,628
+13,783
+23% +$920K 0.08% 266
2021
Q1 		$3.93M Sell
60,845
-18,612
-23% -$1.2M 0.08% 270
2020
Q4 		$4.63M Buy
79,457
+74,634
+1,547% +$4.5M 0.09% 241
2020
Q3 		$305K Sell
4,823
-585
-11% -$40.6K 0.03% 493
2020
Q2 		$416K Sell
5,408
-8,005
-60% -$613K 0.04% 391
2020
Q1 		$1M Buy
+13,413
New +$927K 0.12% 193
2018
Q4 		– Sell
-4,984
Closed -$389K – 473
2018
Q3 		$389K Buy
4,984
+149
+3% +$11.3K 0.06% 319
2018
Q2 		$342K Sell
4,835
-3,767
-44% -$266K 0.06% 305
2018
Q1 		$655K Sell
8,602
-85
-1% -$6.76K 0.12% 194
2017
Q4 		$621K Sell
8,687
-1,497
-15% -$114K 0.11% 212
2017
Q3 		$822K Sell
10,184
-1,023
-9% -$78.2K 0.18% 159
2017
Q2 		$792K Buy
11,207
+3,288
+42% +$219K 0.19% 139
2017
Q1 		$544K Sell
7,919
-2,606
-25% -$183K 0.15% 177
2016
Q4 		$758K Buy
10,525
+5,612
+114% +$417K 0.25% 104
2016
Q3 		$390K Sell
4,913
-6,786
-58% -$551K 0.17% 156
2016
Q2 		$973K Sell
11,699
-26
-0.2% -$2.31K 0.38% 71
2016
Q1 		$1.08M Buy
11,725
+194
+2% +$17.5K 0.47% 55
2015
Q4 		$1.17M Buy
+11,531
New +$1.2M 0.54% 52

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cetera Investment Advisers's GILD Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Gilead Sciences (GILD) stake by 0.68% in Q1 2026, selling an estimated $391K and leaving 404,797 shares worth $56.4M. The position accounts for 0.06% of the portfolio, ranked #334.

Cetera Investment Advisers first reported a position in GILD in Q4 2015 and has held it in 37 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Cetera Investment Advisers held 404,797 shares of Gilead Sciences worth $56.4M as of Q1 2026.
  • Cetera Investment Advisers sold 2,789 Gilead Sciences shares in Q1 2026, an estimated $391K.
  • Gilead Sciences made up 0.06% of Cetera Investment Advisers's portfolio in Q1 2026, its #334 holding.
  • Cetera Investment Advisers first reported a position in Gilead Sciences in Q4 2015 and has held it in 37 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.